This project is aimed at determining the molecular basis for CD4 T cell regulatory functions in the intestinal mucosa. We have previously shown that the majority to T cells in the intestinal lamina propria have the CD4+, Leu-8 - phenotype and that the Leu-8 molecule is the human lymph node homing receptor. A particular focus during the present period has been to determine the mechanisms by which CD4 T cell subpopulations mediate helper activity vs. inhibitory activity for B cell differentiation. Activated CD4+, Leu-8+ T cells had substantially lower levels of mRNA for IL-2, IL-4, IL-5 and IFN-gamma than CD4+, Leu-8- T cells. However, mRNA levels for actin, c-myc lL-2R and TGF-beta were similar in both subsets. Addition of IL-1, IL-2, IL-5, IL-6 or low molecular weight BCGF to pokeweed mitogen (PWM)-stimulated cultures did not reverse the low helper activity of CD4+, Leu-8+ T cells. Most importantly, in PWM-stimulated cultures containing B cells and CD4+, Leu-8- helper T cells, CD4+, Leu-8+ T cells suppressed Ig production when they were in direct contact with B cells. In contrast, there was little suppression when CD4+, Leu-8+ T cells were separated from B cells by a millipore membrane. Thus, the low helper activity of CD4+, Leu-8+ T cells may be due to an inherently lower capacity to produce B cell differentiation factors; their suppressor activity requires T-B contact and may be due to the release of novel inhibitory factors or a cytolytic mechanism. Future studies will determine the role of the Leu 8 molecule in contact dependent lymphocyte function and the mechanism of suppressor function of CD4+, Leu-8+ T cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000432-05
Application #
3809652
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1990
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Strober, Warren; Kitani, Atsushi; Fichtner-Feigl, Stefan et al. (2009) The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillance. Curr Mol Med 9:740-50
Fichtner-Feigl, Stefan; Fuss, Ivan J; Young, Cheryl A et al. (2007) Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol 178:5859-70
Boirivant, Monica; Strober, Warren (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23:679-92
Fuss, Ivan J; Becker, Christoph; Yang, Zhiqiong et al. (2006) Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis 12:9-15
Strober, Warren; Fuss, Ivan J (2006) Experimental models of mucosal inflammation. Adv Exp Med Biol 579:55-97
Leon, Francisco; Contractor, Nikhat; Fuss, Ivan et al. (2006) Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis. J Immunol 177:6974-82
Oida, Takatoku; Xu, Lili; Weiner, Howard L et al. (2006) TGF-beta-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling. J Immunol 177:2331-9
Fichtner-Feigl, Stefan; Strober, Warren; Kawakami, Koji et al. (2006) IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 12:99-106
Strober, Warren (2006) Immunology. Unraveling gut inflammation. Science 313:1052-4
Di Giacinto, Claudia; Marinaro, Mariarosaria; Sanchez, Massimo et al. (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174:3237-46

Showing the most recent 10 out of 22 publications